Your browser doesn't support javascript.
loading
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
Utsunomiya, Masako; Dobashi, Hiroaki; Odani, Toshio; Saito, Kazuyoshi; Yokogawa, Naoto; Nagasaka, Kenji; Takenaka, Kenchi; Soejima, Makoto; Sugihara, Takahiko; Hagiyama, Hiroyuki; Hirata, Shinya; Matsui, Kazuo; Nonomura, Yoshinori; Kondo, Masahiro; Suzuki, Fumihito; Nawata, Yasushi; Tomita, Makoto; Kihara, Mari; Yokoyama-Kokuryo, Waka; Hirano, Fumio; Yamazaki, Hayato; Sakai, Ryoko; Nanki, Toshihiro; Koike, Ryuji; Miyasaka, Nobuyuki; Harigai, Masayoshi.
Affiliation
  • Utsunomiya M; Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo.
  • Dobashi H; Departments of Pharmacovigilance.
  • Odani T; Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo.
  • Saito K; Department of Rheumatology, Musashino Red Cross Hospital, Musashino, Tokyo.
  • Yokogawa N; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kida-gun, Kagawa.
  • Nagasaka K; Third Department of Internal Medicine, Obihiro-Kosei General Hospital, Obihiro, Hokkaido.
  • Takenaka K; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka.
  • Soejima M; Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo.
  • Sugihara T; Departments of Pharmacovigilance.
  • Hagiyama H; Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo.
  • Hirata S; Department of Rheumatology, Ome Municipal General Hospital, Ome, Tokyo.
  • Matsui K; Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo.
  • Nonomura Y; Department of Rheumatology, Ome Municipal General Hospital, Ome, Tokyo.
  • Kondo M; Department of Rheumatology, Ome Municipal General Hospital, Ome, Tokyo.
  • Suzuki F; Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo.
  • Nawata Y; Department of Rheumatology, Yokohama City Minato Red Cross Hospital, Yokohama, Kanagawa.
  • Tomita M; Department of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Graduate School of Medicine, Kumamoto, Kumamoto.
  • Kihara M; Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba.
  • Yokoyama-Kokuryo W; Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo.
  • Hirano F; Department of Rheumatology, Faculty of Medicine, Shimane University, Izumo, Shimane.
  • Yamazaki H; Department of Rheumatology, Soka Municipal Hospital, Soka, Saitama.
  • Sakai R; Center for Rheumatic Disease, Chibaken Saiseikai Narashino Hospital, Narashino, Chiba.
  • Nanki T; Clinical Research Center, Medical Hospital of Tokyo Medical and Dental University.
  • Koike R; Departments of Pharmacovigilance.
  • Miyasaka N; Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo.
  • Harigai M; Departments of Pharmacovigilance.
Rheumatol Adv Pract ; 4(2): rkaa029, 2020.
Article in En | MEDLINE | ID: mdl-33134810
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Rheumatol Adv Pract Year: 2020 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Rheumatol Adv Pract Year: 2020 Document type: Article Country of publication: Reino Unido